Perrigo chief executive and chairman Joe Papa.  Photograph: Brenda Fitzsimons / The Irish Times

Perrigo, the Irish specialist in over the counter drugs, has agreed to buy a portfolio of products from GlaxoSmithKline. GSK’s consumer healthcare div(...)

Robert J. Coury, vice chairman and chief executive officer of Mylan told investors he may sweeten the company’s cash-and-stock offer for  Perrigo, which has rejected Mylan’s most recent offer of $75 in cash and 2.3 Mylan shares for each Perrigo share. (Photograph: Mannie Garcia/Bloomberg News)

Mylan’s chairman told investors he may sweeten the company’s cash-and-stock offer for Irish headquartered Perrigo by adding terms to reduce the risk (...)

Robert J. Coury, vice-chairman and chief executive of Mylan. Photographer: Mannie Garcia/Bloomberg News

Generic drugs group Mylan boosted its cash-and-stock offer to buy Irish company Perrigo to $34.10 billion, but the bid was swiftly rejected.Mylan’s p(...)

Robert Coury, chief executive of Mylan pharmacutical company. Photograph: Alan Betson / THE IRISH TIMES

Generic drugmaker Mylan says it will take its $31 billion offer for Perrigo directly to shareholders, in what is set to be one of the most high-profil(...)

Joe Papa CEO and president of Perrigo, which has rejected a $29 billion bid from rival Mylan. Photograph: Brenda Fitzsimons / THE IRISH TIMES

Dublin-based Perrigo has rejected a $29 billion bid from generics group Mylan. The company said its board unanimously rejected the $205 per share offe(...)

Joe Papa, CEO and president of Perrigo

The ripple effect of the wave of corporate inversion in the pharma/medtech sector continues to drive the ongoing wave of consolidation.Less than two y(...)

A generic form of the drug Plavix sits on crates at a Mylan Pharmaceuticals distribution centre in North Carolina.  Mylan has offered to acquire Perrigo for about $29 billion in what would be the latest mega-merger among drug makers if it is completed. Photograph: Travis Dove/The New York Times

Drugmaker Mylan offered to buy rival Perrigo for $28.9 billion in a deal that would create a powerhouse for generic medicine. Mylan, which makes abo(...)

Joe Papa CEO and president of Perrigo, which has announced it will acquire Belgium’s Omega Pharma in a €3.6 billion deal.  Photograph: Brenda Fitzsimons / THE IRISH TIMES

Perrigo, the Irish-domiciled consumer pharma group that bought Elan last year, has announced plans to acquire Belgium’s Omega Pharma for €3.6 billi(...)

Steven Cohen: a judge ruled yesterday that the entire case against him and SAC can go forward. Photograph: Scott Eells/Bloomberg

A US federal judge has rejected billionaire investor Steven A Cohen’s bid to dismiss lawsuits by shareholders of pharma firms Elan and Wyeth who clai(...)

Global healthcare firm Perrigo, which has experienced somewhat volatile earnings recently, is due to report fourth quarter results on Thursday.Analyst(...)